Abstract
Influenza virus is the pathogen responsible for the epidemic influenza and current vaccines include inactivated and live attenuated viruses which are produced in chicken eggs. However, these vaccines posses various drawbacks of their own and the protection rate ranges from 30-80% depending on match between strains included in the vaccine and circulating strains, leaving significant room for improvement. This review provides background information regarding the influenza vaccines and extends the discussion with an emphasis on the new patents published or granted over the last five years. These patents primarily aim at ameliorating existing bottlenecks in vaccine development and are associated with vaccine compositions that provide strong vaccine efficacies and broader cross-reactivity, and various vaccine platforms such as DNA vaccines, recombinant subunit, peptide and viral vector vaccines.
Keywords: Influenza vaccine, influenza virus, DNA vaccine, inactivated virus vaccine, attenuated virus, reverse genetics, adjuvant, subunit vaccine, peptide vaccine
Recent Patents on Biotechnology
Title: Recent Patents on Influenza Vaccines
Volume: 1 Issue: 3
Author(s): Yu-Chen Hu and Chi-Yuan Chen
Affiliation:
Keywords: Influenza vaccine, influenza virus, DNA vaccine, inactivated virus vaccine, attenuated virus, reverse genetics, adjuvant, subunit vaccine, peptide vaccine
Abstract: Influenza virus is the pathogen responsible for the epidemic influenza and current vaccines include inactivated and live attenuated viruses which are produced in chicken eggs. However, these vaccines posses various drawbacks of their own and the protection rate ranges from 30-80% depending on match between strains included in the vaccine and circulating strains, leaving significant room for improvement. This review provides background information regarding the influenza vaccines and extends the discussion with an emphasis on the new patents published or granted over the last five years. These patents primarily aim at ameliorating existing bottlenecks in vaccine development and are associated with vaccine compositions that provide strong vaccine efficacies and broader cross-reactivity, and various vaccine platforms such as DNA vaccines, recombinant subunit, peptide and viral vector vaccines.
Export Options
About this article
Cite this article as:
Hu Yu-Chen and Chen Chi-Yuan, Recent Patents on Influenza Vaccines, Recent Patents on Biotechnology 2007; 1 (3) . https://dx.doi.org/10.2174/187220807782330192
DOI https://dx.doi.org/10.2174/187220807782330192 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
Call for Papers in Thematic Issues
Advancements in Plant Genetics and Genomics
This thematic issue will highlight cutting-edge innovations and recent patents across the breadth of plant genetics and genomics. Key topics will include advanced breeding techniques, omics-based approaches, gene editing, trait discovery, and translational applications for crop improvement. Renowned researchers from leading institutions worldwide will provide state-of-the-art insights and future perspectives ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
miRNAs in the Biology of Cancers and Viral Infections
Current Medicinal Chemistry Epigenetic Mechanism Involved in the HBV/HCV-Related Hepatocellular Carcinoma Tumorigenesis
Current Pharmaceutical Design Experimental Onco-Immunology Revisited
Current Cancer Therapy Reviews pH-Sensitive Polymer-Based Carriers as a Useful Approach for Oral Delivery of Therapeutic Protein: A Review
Protein & Peptide Letters Notch Signalling Pathways and Their Importance in the Treatment of Cancers
Current Drug Targets O6-Alkylguanine-DNA Alkyltransferase Inactivation in Cancer Chemotherapy
Mini-Reviews in Medicinal Chemistry Alpha9Alpha10 Nicotinic Acetylcholine Receptors as Target for the Treatment of Chronic Pain
Current Pharmaceutical Design Exploration of Metastasis-related Proteins as Biomarkers and Therapeutic Targets in the Treatment of Head and Neck Cancer
Current Cancer Drug Targets The HOX Gene Network as a Potential Target for Cancer Therapy
Current Cancer Therapy Reviews Nanopotentiation of Propolis for Revocation of Enzyme Imbalance in UVB Induced Cutaneous Toxicity in Murine Model: a Preliminary Study for Chemoprotection of Skin Cancer
Drug Delivery Letters Synthesis and Biological Evaluation of a Series of 2-(Substitutedphenyl) benzothiazoles
Medicinal Chemistry Biology of Cox-2: An Application in Cancer Therapeutics
Current Drug Targets Chimeric Virus-like Particles of Universal Antigen Epitopes of Coronavirus and Phage Qβ Coat Protein Trigger the Production of Neutralizing Antibodies
Current Topics in Medicinal Chemistry Gamma Secretase Inhibitor: Therapeutic Target via NOTCH Signaling in T Cell Acute Lymphoblastic Leukemia
Current Drug Targets Predictive Biomarkers and Novel Targets in the Treatment of Metastatic Renal Cell Carcinoma
Current Medicinal Chemistry Green Tea Polyphenols as Proteasome Inhibitors: Implication in Chemoprevention
Current Cancer Drug Targets The Functional Role of Oncogenic LncRNA BCAR4 for Cancer Outcome
Current Pharmaceutical Design Targeting Basal-Like Breast Cancers
Current Drug Targets Tracking Cell Signaling Protein Expression and Phosphorylation by Innovative Proteomic Solutions
Current Pharmaceutical Biotechnology Behavioral Decision Research Intervention Reduces Risky Sexual Behavior
Current HIV Research